• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cytokine receptor-like factor 1 (CRLF1)

ACP01842

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01842 Target NameCRLF1
Target SynonymsCytokine-like factor 1 Short name: CLF-1 ZcytoR5FormLiquid or Lyophilized powder
Expression SystemBaculovirusExpression Range38-422aa
Mol Weight46.5 kDaProtein LengthFull Length of Mature Protein
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO75462
Background Information
  • Uniprot Id

    O75462

  • Target Species

    Human

  • Target Name

    CRLF1

  • Target Full Name

    Cytokine receptor-like factor 1

  • Target Function

    In complex with CLCF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development (Probable). May also play a regulatory role in the immune system.

  • Target Involvement

    Cold-induced sweating syndrome 1 (CISS1)

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Type I cytokine receptor family, Type 3 subfamily

  • Target Tissue Specificity

    Highest levels of expression observed in spleen, thymus, lymph node, appendix, bone marrow, stomach, placenta, heart, thyroid and ovary. Strongly expressed also in fetal lung.

  • Target Research Area

    Immunology

  • Target Synonyms

    CRLF1; UNQ288/PRO327Cytokine receptor-like factor 1; Cytokine-like factor 1; CLF-1; ZcytoR5

Inquire Recombinant Human Cytokine receptor-like factor 1 (CRLF1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification